Yihai Cao Selected Research

Neurokinin-1 Receptors (Neurokinin 1 Receptor)

11/2021	A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
1/2019	Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yihai Cao Research Topics

Disease

110	Neoplasms (Cancer) 05/2024 - 02/2002
34	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2002
15	Hypoxia (Hypoxemia) 01/2023 - 06/2006
10	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2008
10	Obesity 01/2024 - 02/2004
9	Lymphatic Metastasis 09/2014 - 06/2002
8	Pathologic Neovascularization 01/2023 - 06/2004
8	Vascular Remodeling 01/2020 - 02/2005
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 09/2008
6	Inflammation (Inflammations) 01/2022 - 07/2002
6	Fibrosarcoma 01/2020 - 02/2002
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 04/2006
5	Retinal Neovascularization 10/2017 - 03/2008
4	Melanoma (Melanoma, Malignant) 10/2023 - 06/2015
4	Fibrosis (Cirrhosis) 01/2023 - 08/2011
4	COVID-19 12/2022 - 01/2021
4	Insulin Resistance 10/2014 - 06/2004
3	Leukemia 04/2024 - 01/2019
3	Body Weight (Weight, Body) 12/2022 - 04/2006
3	Ischemia 01/2020 - 05/2003
3	Anemia 10/2014 - 12/2011
2	Weight Loss (Weight Reduction) 01/2024 - 12/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 10/2018
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2022
2	Infections 12/2022 - 10/2021
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 10/2022 - 01/2022
2	Atherosclerosis 04/2022 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2021
2	Vomiting 11/2021 - 01/2019
2	Nausea 11/2021 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 06/2015
2	Adenocarcinoma of Lung 01/2021 - 08/2012
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 07/2013
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2018 - 10/2014
2	Retinal Degeneration 10/2018 - 10/2014
2	Cataract (Cataracts) 11/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

45	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2002
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2002
12	Oxygen (Dioxygen)IBA 01/2023 - 06/2006
12	Angiogenesis InhibitorsIBA 01/2019 - 07/2002
11	Becaplermin (PDGF-BB)FDA Link 01/2018 - 05/2003
11	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2015 - 10/2004
9	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021 - 06/2002
8	CytokinesIBA 10/2023 - 02/2005
8	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2008
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 10/2005
6	Retinaldehyde (Retinal)IBA 01/2020 - 07/2008
6	Sunitinib (Sutent)FDA Link 01/2016 - 07/2008
5	Vascular Endothelial Growth Factor BIBA 01/2023 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2018
4	Interleukin-33IBA 01/2022 - 01/2016
4	Vascular Endothelial Growth Factor CIBA 09/2012 - 06/2002
4	LigandsIBA 01/2010 - 06/2002
3	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2008
3	CollagenIBA 01/2023 - 01/2003
3	Messenger RNA (mRNA)IBA 11/2022 - 12/2011
3	IntegrinsIBA 01/2020 - 03/2014
3	Estrogen ReceptorsIBA 10/2019 - 08/2015
3	LipidsIBA 01/2019 - 07/2013
3	Blocking AntibodiesIBA 12/2018 - 01/2013
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2018 - 01/2013
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2018 - 07/2010
3	Erythropoietin FDA Link 11/2017 - 12/2011
3	MorpholinosIBA 11/2015 - 11/2009
3	platelet-derived growth factor C (PDGF-C)IBA 10/2014 - 04/2010
3	FilaminsIBA 02/2014 - 03/2007
3	Angiogenesis Modulating AgentsIBA 01/2014 - 01/2009
3	Small Interfering RNA (siRNA)IBA 01/2013 - 07/2010
3	Platelet-Derived Growth FactorIBA 01/2013 - 02/2005
2	Interleukin-6 (Interleukin 6)IBA 05/2024 - 01/2020
2	mirabegronIBA 11/2023 - 01/2019
2	elemeneIBA 10/2023 - 01/2022
2	Protein Isoforms (Isoforms)IBA 01/2023 - 02/2002
2	Angiopoietin-2IBA 01/2023 - 04/2006
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2006
2	HydrogelsIBA 12/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	Hormones (Hormone)IBA 11/2021 - 12/2009
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2021 - 01/2019
2	AntigensIBA 11/2021 - 05/2010
2	Polo-Like Kinase 1IBA 01/2021 - 01/2021
2	Phosphorus (Red Phosphorus)IBA 11/2020 - 01/2018
2	NucleotidesIBA 01/2020 - 01/2011
2	Choline (Choline Chloride)IBA 10/2019 - 10/2016
2	Apolipoproteins E (ApoE)IBA 01/2019 - 07/2013
2	ApolipoproteinsIBA 01/2019 - 07/2013
2	LDL Receptors (LDL Receptor)IBA 01/2019 - 07/2013
2	Jagged-1 ProteinIBA 11/2017 - 01/2017
2	Tamoxifen FDA LinkGeneric 10/2016 - 08/2015
2	Neutralizing AntibodiesIBA 04/2016 - 07/2010

Therapy/Procedure

54	Therapeutics 01/2023 - 06/2002
11	Drug Therapy (Chemotherapy) 11/2022 - 01/2008
5	Immunotherapy 10/2023 - 01/2020
3	Radiotherapy 01/2022 - 01/2015
2	Precision Medicine 01/2021 - 01/2020
2	Photothermal Therapy 12/2020 - 01/2020